| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.35B | 113.83B | 110.39B | 105.20B | 106.17B | 95.71B |
| Gross Profit | 60.58B | 63.76B | 62.14B | 57.27B | 54.17B | 45.19B |
| EBITDA | 45.15B | 46.96B | 47.00B | 36.80B | 36.60B | 29.82B |
| Net Income | 26.61B | 28.01B | 27.74B | 21.38B | 20.68B | 16.67B |
Balance Sheet | ||||||
| Total Assets | 154.99B | 165.10B | 151.82B | 140.37B | 128.17B | 130.52B |
| Cash, Cash Equivalents and Short-Term Investments | 25.84B | 16.66B | 34.98B | 35.33B | 29.29B | 29.36B |
| Total Debt | 19.62B | 16.51B | 21.08B | 23.20B | 19.93B | 19.56B |
| Total Liabilities | 59.48B | 55.74B | 55.90B | 55.25B | 54.39B | 65.94B |
| Stockholders Equity | 95.51B | 109.36B | 95.92B | 85.12B | 72.90B | 63.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.83B | 26.36B | 17.92B | 10.63B | 21.06B |
| Operating Cash Flow | 0.00 | 27.54B | 40.43B | 28.40B | 21.34B | 25.80B |
| Investing Cash Flow | 0.00 | -25.06B | -22.32B | -11.27B | -9.45B | -12.43B |
| Financing Cash Flow | 0.00 | -21.44B | -21.29B | -10.73B | -12.54B | -5.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥692.32B | 24.15 | ― | 2.18% | 3.12% | 2.74% | |
78 Outperform | ¥927.58B | 27.98 | 8.07% | 2.85% | 11.53% | 1.60% | |
76 Outperform | ¥37.74B | 21.13 | 3.48% | 2.38% | 2.67% | 0.64% | |
74 Outperform | ¥527.23B | 14.82 | 6.30% | 2.16% | 4.78% | ― | |
74 Outperform | ¥1.36T | 35.16 | 15.75% | 1.08% | 18.84% | 42.10% | |
70 Outperform | ¥17.75T | 75.03 | 8.95% | 1.88% | 5.02% | 2.02% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |